Solu-cortef and Ancef drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Solu-cortef (hydrocortisone sodium succinate) and Ancef (cefazolin sodium). Common drug interactions include acute respiratory distress syndrome among females and anhedonia among males.
The phase IV clinical study analyzes what interactions people have when they take Solu-cortef and Ancef. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.
What is Solu-cortef?
Solu-cortef has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 7,983 Solu-cortef users. Check the latest studies of Solu-cortef.
What is Ancef?
Ancef has active ingredients of cefazolin sodium. eHealthMe is studying from 3,292 Ancef users. Check the latest studies of Ancef.
36 people who take Solu-cortef and Ancef together, and have interactions are studied.

What are the common drug interactions of Solu-Cortef and Ancef, by gender? *:
female:
- Acute respiratory distress syndrome
- Acute respiratory failure
- Adams-stokes syndrome (sudden attacks of unconsciousness)
- Alopecia areata (patchy baldness that typically begins with rapid hair loss)
- Alopecia totalis (loss of all head hair)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Atrioventricular block (heart block)
- Blood glucose increased
- Blood pressure fluctuation
male:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Stress
- Death
- Dyspnoea (difficult or laboured respiration)
- Oedema peripheral (superficial swelling)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Abdominal distension
- Anaemia (lack of blood)
- Asbestosis (chronic lung disease caused by scarring of lung tissue, which stems from prolonged exposure to asbestos)
What are the common drug interactions of Solu-Cortef and Ancef, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Abdominal sepsis (abdominal infection)
- Pulmonary embolism (blockage of the main artery of the lung)
- Small intestinal obstruction (blockage in small intestine)
20-29:
- Abortion (termination of pregnancy)
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Injury
- Pain
- Postoperative thrombosis (formation of a blood clot inside a blood vessel after operative)
30-39:
n/a
40-49:
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Hypertension (high blood pressure)
- Hyperthermia (body temperature greatly above normal)
- Oxygen saturation decreased
- Psychomotor hyperactivity (feelings of extreme restlessness)
- Pulmonary oedema (fluid accumulation in the lungs)
- Respiratory distress (difficulty in breathing)
- Tachypnoea (a condition of rapid breathing over 20 per minute)
50-59:
- Asthenia (weakness)
- Diarrhoea
- Enterocolonic fistula
- Fatigue (feeling of tiredness)
- Groin pain
- Hair colour changes
- Hydrocele
- Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
- Large intestine perforation (hole in large intestine)
- Malaise (a feeling of general discomfort or uneasiness)
60+:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Renal impairment (severely reduced kidney function)
- Death
- Dyspnoea (difficult or laboured respiration)
- Oedema peripheral (superficial swelling)
- Pleural effusion (water on the lungs)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Abdominal distension
- Anaemia (lack of blood)
What are the existing conditions these people have? *
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 13.89%
- Pain: 5 people, 13.89%
- Hypersensitivity: 5 people, 13.89%
- Rickets (softening of bones): 5 people, 13.89%
- Muscle Spasms (muscle contraction): 5 people, 13.89%
- High Blood Pressure: 4 people, 11.11%
- Hyperglycemia (high blood sugar): 4 people, 11.11%
- Diarrhea: 4 people, 11.11%
- Nausea (feeling of having an urge to vomit): 4 people, 11.11%
- Urinary Tract Infection: 4 people, 11.11%
* Approximation only. Some reports may have incomplete information.
Do you take Solu-cortef and Ancef?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Solu-cortef (7,983 reports)
- Ancef (3,292 reports)
Browse all drug interactions of Solu-cortef and Ancef:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Solu-cortef:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ancef:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Solu-cortef and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ancef and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on hydrocortisone sodium succinate and cefazolin sodium (the active ingredients of Solu-cortef and Ancef, respectively), and Solu-cortef and Ancef (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hydrocodone Bitartrate And Ibuprofen vs. Indomethacin, side effect and effectiveness comparison - 18 seconds ago
- Drug interactions of Betapace and Atorvastatin Calcium - 26 seconds ago
- Thyroid Diseases and Gout Aggravated - 30 seconds ago
- Drug interactions of Zonisamide and Vitamin B12 - 33 seconds ago
- Could Axid cause Urticaria? - 34 seconds ago
- Could Escitalopram cause Abdominal Mass? - 41 seconds ago
- Could Nasonex cause Fungal Infection? - 42 seconds ago
- Drug interactions of Cipro and Niacin - 50 seconds ago
- Multiple Myeloma and Angina Pectoris Aggravated - 53 seconds ago
- How effective is Glyburide for Diabetes Mellitus Non-Insulin-Dependent? - a minute ago